偶氮甲烷
偶氮甲烷 性质
沸点 | 97-99 °C (lit.) |
---|---|
密度 | 0.991 g/mL at 25 °C (lit.) |
折射率 | 1.4368 (estimate) |
闪点 | 24 °C |
储存条件 | -20°C |
溶解度 | 溶于水、乙醇、乙醚 |
形态 | 液体 |
颜色 | 油状 |
比重 | 0.991 |
InChI | InChI=1S/C2H6N2O/c1-3-4(2)5/h1-2H3 |
InChIKey | DGAKHGXRMXWHBX-UHFFFAOYSA-N |
SMILES | [N+]([O-])(C)=NC |
EPA化学物质信息 | Azoxymethane (25843-45-2) |
偶氮甲烷 用途与合成方法
Azoxymethane is a colon carcinogen which leads to the formation of DNA adducts. On an equal protein basis, hepatic microsomes are much more active than SI and colon microsomes in NADPH-dependent Azoxymethane bioactivation and N 7 -mG adduct formation. Hepatic microsomes show the highest activity in the hydroxylation of Azoxymethane, followed by SI and colon microsomes.
Regardless of the strain, the amounts of O 6 -mG and N 7 -mG produced by Azoxymethane are highest in the liver, followed by proximal and distal colons, which have similar levels, and then by duodenum, jejunum and ileum. Results indicate that the Azoxymethane-induced DNA adduct formation in the SI and colon does not depend on bioactivation by hepatic P450 enzymes. Irrespective of the mouse strain, no aberrant crypt foci (ACF) is detected in the colons of saline-treated mice; in contrast, colonic ACF is detected in all three strains of Azoxymethane-treated mice. The Azoxymethane-treated athymic mice have approximately an 11-fold lower tumor incidence than similarly treated WT animals.
安全信息
危险品标志 | T |
---|---|
危险类别码 | 45-46-10-25-34-36/38 |
安全说明 | 53-26-36/37/39-45 |
危险品运输编号 | UN 1992 3/PG 3 |
WGK Germany | 3 |
RTECS号 | PA2975000 |
毒性 | mma-sat 13,600 mmol/L/20M CNREA8 38,4585,78 |
偶氮甲烷 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-11-11 | XW2584345201 | 氧化偶氮甲烷 | 100mg | 22671 | |
2024-11-08 | HY-111375 | 偶氮甲烷 | 25843-45-2 | 5mg(135mM * 500μL in Water) | 2650 |